
Peptide
AOD-9604
A short synthetic peptide corresponding to a tail-end fragment of human growth hormone, with one extra building block added at the front.
- Specification
- greater than or equal to 99.93 percent
- Measured lot value
- Testing in progress
A defined 28-amino-acid peptide (thymalfasin) — the single-molecule counterpart to the thymus extract elsewhere in its collection. A crystalline solid.
$43.20
5 mg / vial · $8.64 / mg
Quantity
Add 1 more for 3% off
Bundle & save
1 vial
$43.20
each
2 vials
$41.90
3% off
3+ vials
$41.04
5% off
Per-vial price shown. The discount applies automatically at checkout.
Purchase options
Verification
Every batch is identified by a lot number, and its third-party certificate is listed here by lot. Measured values are shown only when they are real and independently verifiable.
Third-party testing in progress
We are currently having this product independently tested by a third-party laboratory. Its certificate of analysis will be published here as soon as the results are available — please check back soon. For laboratory research use only.
Thymosin Alpha-1, also known as thymalfasin, is a defined peptide of twenty-eight amino acids. It is filed in the senescence and cellular-longevity research collection.
We supply it as a single reference lot, prepared for third-party purity testing, with each lot's certificate on its verification page.
It pairs naturally with the thymus extract listed elsewhere in this collection: where that item is a mixture, this is a single, fully defined peptide — a clean, well-characterized reference standard of known length. That contrast is a tidy illustration of the difference between a defined compound and a heterogeneous extract.
For laboratory research use only. Not for human or veterinary use.
Thymosin Alpha-1 (thymalfasin) is a defined 28-residue thymic peptide studied in immune-signaling research. It is the single-molecule counterpart to the thymus extract in its collection and is catalogued in senescence and cellular-longevity research.
Independent peer-reviewed literature that references Thymosin Alpha-1.
Thymosin alpha-1
Ancell CD et al.
Am J Health Syst Pharm2001
View source for Thymosin alpha-1 (opens in a new tab)Thymosin alpha-1 treatment in chronic hepatitis B
Wu X et al.
Expert Opin Biol Ther2015
View source for Thymosin alpha-1 treatment in chronic hepatitis B (opens in a new tab)Immune Modulation with Thymosin Alpha 1 Treatment
King R et al.
Vitam Horm2016
View source for Immune Modulation with Thymosin Alpha 1 Treatment (opens in a new tab)Thymosin alpha 1: A comprehensive review of the literature
Dominari A et al.
World J Virol2020
View source for Thymosin alpha 1: A comprehensive review of the literature (opens in a new tab)Citations are provided for educational and scientific reference only. They describe independent published research and are not product claims — they do not represent the performance, purity, or intended use of any material offered for sale.
General handling guidance for laboratory research materials — always defer to the product label and the lot certificate of analysis.
Research use only
For laboratory research use only. Not for human or veterinary use.
No reviews yet
Reviews are published only from verified purchases, so none appear until orders ship.

Peptide
A short synthetic peptide corresponding to a tail-end fragment of human growth hormone, with one extra building block added at the front.

Peptide
A synthetic peptide of fifteen building blocks (a pentadecapeptide), based on a partial sequence of a protein first identified in gastric juice.

Peptide blend
A blend of two peptides — BPC-157 and TB-500 — supplied together. A mixture, not a single substance, with no identity of its own.

Peptide
A growth-hormone-releasing factor analogue of twenty-nine building blocks, also known as Modified GRF (1-29). Easily confused with the closely related sermorelin.